The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef

Index of Online Supplemental Material for
J. Exp. Med. 10.1084/jem.20072102
Liu et al.

Figure S1 Methylation-specific PCR confirmed cyclin D1 promoter DNA hypomethylation in MCL cell lines Granta (G) and NCEB (N), and methylation in mutant cell lines G4 and N1.

Figure S2 Bisulfite sequencing analysis of a 1:1 mix of genomic DNA and nonhomologous recombinant cell lines.

Figure S3 FISH analysis of a variant MCL patient, demonstrating loss of one cyclin D1 allele in the neoplastic lymphocytes.

Figure S4 Western blot analysis of protein levels of cyclin D1 and transcription factors in cell lines.

Figure S5 Immunofluorescent staining of an MCL patient sample.

Figure S6 TUNEL assays of G and N parental cell lines, and the G4 and N1 mutant cells lacking the translocated chromosome after infection with retroviruses containing the NPM shRNA or a control shRNA.

Supplemental text and Table S1 (PDF)





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef


  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS